Related Experiment Video
Updated: May 17, 2026
Isolation of CD133+ Liver Stem Cells for Clonal Expansion
Published on: October 10, 2011
STAT3 & Cytochrome P450 2C9: a novel signaling pathway in liver cancer stem cells
Sun Jung Myung1, Jung-Hwan Yoon, Su Jong Yu
1Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, Republic of Korea.
Abstract:
Although cancer stem cells (CSCs) are believed to be the key drivers in tumor growth and resistance to therapy, the specific signaling of CSCs is largely unknown. In this study, we evaluated the roles of hypoxia and STAT3 signaling on the treatment resistance of CSCs. Side population (SP) cell analysis and sorting were used to detect subpopulations that function as CSCs. Huh-7 cells, doxorubicin, sulfaphenazole (a CYP2C9 inhibitor), and AG490 (a STAT3 inhibitor) were used in this study. Cell growth and apoptosis were assessed using MTS assays, and apoptotic and kinase signaling pathways were explored by immunoblotting. Treatment with IL-6 induced STAT3 activation more significantly in SP than non-SP cells. Hypoxia induced SP cell proliferation, and microarray analysis showed that the expression of CYP2C9 was significantly increased in hypoxic than normoxic SP cells. Although hypoxic SP cells were less sensitive to doxorubicin-induced apoptosis, pretreatment with sulfaphenazole sensitized hypoxic SP cells to doxorubicin cytotoxicity. These results indicate that STAT3 is critical for CSC survival and hypoxia-inducible CYP2C9 expression is responsible the doxorubicin resistance of CSCs under hypoxic conditions. Thus, the selective inhibition of CYP2C9 and STAT3 may be implicated in the sensitization of CSCs to anti-cancer treatment, particularly in advanced cases.
Insights
Cancer stem cells (CSCs) drive tumor growth and therapy resistance. Hypoxia and STAT3 signaling promote CSC survival and doxorubicin resistance via CYP2C9, suggesting dual inhibition for enhanced cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Cancer stem cells (CSCs) are implicated in tumor progression and therapeutic resistance.
- The specific signaling pathways governing CSC behavior, particularly under hypoxic conditions, remain incompletely understood.
Purpose of the Study:
- To investigate the roles of hypoxia and STAT3 signaling in the treatment resistance of cancer stem cells (CSCs).
- To identify the molecular mechanisms underlying CSC resistance to chemotherapy, specifically doxorubicin.
Main Methods:
- Utilized side population (SP) cell analysis and sorting to isolate CSC subpopulations.
- Employed MTS assays for cell growth and apoptosis assessment, and immunoblotting for signaling pathway analysis.
- Investigated the effects of IL-6, hypoxia, and inhibitors (sulfaphenazole, AG490) on CSCs.
Main Results:
- STAT3 activation was significantly higher in SP cells (CSCs) compared to non-SP cells upon IL-6 treatment.
- Hypoxia promoted SP cell proliferation and increased the expression of CYP2C9 in hypoxic SP cells.
- Hypoxic SP cells exhibited reduced sensitivity to doxorubicin, which was reversed by sulfaphenazole pretreatment.
Conclusions:
- STAT3 signaling is crucial for CSC survival.
- Hypoxia-induced CYP2C9 expression confers doxorubicin resistance in CSCs.
- Targeting both CYP2C9 and STAT3 may enhance anti-cancer therapy efficacy, especially in advanced cancer stages.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
01:24Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...